Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.
Maitland-van der Zee AH, Lynch A, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C, Ford CE, Eckfeldt JH. Maitland-van der Zee AH, et al. Pharmacogenet Genomics. 2008 Aug;18(8):651-6. doi: 10.1097/FPC.0b013e3282fe1759. Pharmacogenet Genomics. 2008. PMID: 18622257 Free PMC article. Clinical Trial.
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.
Maitland-van der Zee AH, Peters BJ, Lynch AI, Boerwinkle E, Arnett DK, Cheng S, Davis BR, Leiendecker-Foster C, Ford CE, Eckfeldt JH. Maitland-van der Zee AH, et al. Pharmacogenet Genomics. 2009 May;19(5):338-44. doi: 10.1097/fpc.0b013e32832933b7. Pharmacogenet Genomics. 2009. PMID: 19415820 Free PMC article. Clinical Trial.
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
Lynch AI, Eckfeldt JH, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Arnett DK. Lynch AI, et al. Among authors: leiendecker foster c. Pharmacogenet Genomics. 2012 May;22(5):355-66. doi: 10.1097/FPC.0b013e3283516ff8. Pharmacogenet Genomics. 2012. PMID: 22388798 Free PMC article. Clinical Trial.
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
Maitland-van der Zee AH, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C, Miller MB, Klungel OH, Ford CE, Eckfeldt JH. Maitland-van der Zee AH, et al. Am Heart J. 2007 Jan;153(1):54-8. doi: 10.1016/j.ahj.2006.10.019. Am Heart J. 2007. PMID: 17174637 Free PMC article.
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
Huxley RR, Lopez FL, MacLehose RF, Eckfeldt JH, Couper D, Leiendecker-Foster C, Hoogeveen RC, Chen LY, Soliman EZ, Agarwal SK, Alonso A. Huxley RR, et al. Among authors: leiendecker foster c. PLoS One. 2013;8(3):e59052. doi: 10.1371/journal.pone.0059052. Epub 2013 Mar 15. PLoS One. 2013. PMID: 23554968 Free PMC article.
52 results